Recognition, diagnosis, and management of heparin-induced thrombocytopenia and thrombosis

Plastic and Reconstructive Surgery

Volumn 103, Issue 2, 1999, Pages 559-565

  Clyde Smoot, E ^a  

^a University of Tennessee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DANAPAROID; DEXTRAN; HEPARIN; PROTAMINE SULFATE;

ADULT; AMPUTATION; AORTA BALLOON; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EMBOLECTOMY; FEMALE; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

ANGINA, UNSTABLE; ANTICOAGULANTS; CORONARY ARTERY BYPASS; FEMALE; HEPARIN; HUMANS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0032965022     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199902000-00030     Document Type: Article

References (27)

1. Warkentin, T. E., Levine, M. N., Hirsh, J., et al. Heparin-indiiced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N. Engl.J. Med. 332: 1330, 1995.
2. Chong, B. H., and Berndt, M. C. Heparin-induced thrombocytopenia. Blut 58: 53, 1989.
3. Chong, B. H. Heparin-induced thrombocytopenia. Br. J. Haematol. 89: 431, 1995.
4. King, D.J., and Kelton.J. G. Heparin-associated thrombocytopenia. Ann. Intern. Med. 100: 535, 1984.
5. Warkentin, T. E., and Kclton, J. G. Heparin-induced thrombocytopenia. Prog. Hemosl. Thromb. 10: 1, 1991.
6. Warkentin, T. E., and Kelton, J. G. A 14-year study of heparin-induced thrombocytopenia. Am.J. Med. 101: 502, 1996.
7. Bell, W. R. Heparin-associated thrombocytopenia and thrombosis. JLab. Clin. Med. Ill: 600, 1988.
8. Greinacher, A. Antigen generation in heparin-associated thrombocytopenia: The nonimmunolgic type and the immunologie type are closely linked in their pathogenesis. Semin. Thromb. Hemosl. 21: 106, 1995.
9. Warkentin, T. E., Hayward, C. P. M., Boslikov, L. K., et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84: 3691, 1994.
10. Visentin, G. P., Ford, S. E., Scott, J. P., and Aster, R. H. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. JClin. Invest. 93: 81, 1994.
11. Hunter,J. B., Lonsdale, R.J., Wcnham, R. W., et al. Heparin-induced thrombosis: An important complication of heparin prophylaxis for thromboembolic disease in surgery. Br. Med.J. 307: 53, 1993.
12. Singer, R. L., Mannion.J. D., Bauer, T. L., Annenti, F. R., and Edie, R. N. Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass. Chest 104: 1436, 1993.
13. Warkentin, T. E. Heparin-induced skin lesions. Br, J. Haematol. 92: 494, 1996.
14. Ansell, J., and Deykin, D. Heparin-induced thrombocytopenia and recurrent thromboembolism. Am. J. Hematol. 8: 325, 1980.
15. Greinacher, A., Amiral, J., Duinmel, V., et al. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34: 381, 1994.
16. Stewart, M. S., Etches, W. S., Boslikov, L. K., and Gordon, P. A. Heparin-induced thrombocytopenia: An im-proved method of detection based on lumi-aggregometry. Dr. J. Haematol. 91: 173, 1995.
17. Greinacher, A., Michels, I., Kiefel, V., étal. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb. Haemosl. 66: 734, 1991.
18. Lewis, B. E., Walenga, J. M., and Wallis, D. E. Anticoagiilation with Novastan (Argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Semin. Thromb. Hemost. 23: 197, 1999.
19. Deniers, C., Ginsberg, J. S., Brill-Edwards, P., et al. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood78: 2194, 1991.
20. Magnani, H. N. Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172). Thromb. Haemosl. 70: 554, 1993.
21. Schiele, F., Vuillemenot, A., Kramarz, P., et al. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia. Am.J. Hematol. 50: 20, 1995.
22. Gouault-Heilmann, M., Huet, Y., Adnot, S., et al. Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia. Haemostasis 17: 134, 1987.
23. Warkentin, T. E., Russett.J. L,Johnston, M., et al. Warfarin treatment of deep vein thrombosis complicating heparin-induced thrombocytopenia (HIT) is a risk factor for initiation of venous limb gangrene: Report of nine patients implicating the interacting procoagulant effects of two anticoagulant agents. Thromb. Huemost. 73: 1110, 1995.
24. Warkentin, T. E. Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagiilant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia. Trnnsfiis. Med. Rev. 10: 249, 1996.
25. Addonizio, V. P., Fisher, C. A., Kappa, J. R., and Ellison, N. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374). Surgery 102: 796, 1987.
26. Calligaro, K. D., Kansagrn, A., Dougherty, M.J., et al. Thrombolysis to treat arterial thrombotic complications of heparin-induced thrombocytopenia. Ann. Vase. Surg. 9: 397, 1995.
27. Stone, M. S., and Rosen, T. Acral purpura: An unusual sign of coumarin necrosis. J. Am. Acad. Dennatol. 14: 797, 1986.